tiprankstipranks
Trending News
More News >
Insmed (INSM)
NASDAQ:INSM
US Market
Advertisement

Insmed (INSM) Technical Analysis

Compare
969 Followers

Technical Sentiment

Overall Consensus
Buy
14Bullish
1Neutral
7Bearish
Technical Analysis Consensus
Strong Sell
2Bullish
1Neutral
7Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
Insmed’s (INSM) Moving Averages Convergence Divergence (MACD) indicator is 8.93, suggesting Insmed is a Sell.
Insmed’s (INSM) 20-Day exponential moving average is 131.32, while Insmed’s (INSM) share price is $145.1, making it a Buy.
Insmed’s (INSM) 50-Day exponential moving average is 116.79, while Insmed’s (INSM) share price is $145.1, making it a Buy.

Insmed (INSM) Pivot Points

Sep 07, 2025, 03:53 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
137.10
139.18
140.85
142.93
144.60
146.68
148.35
Fibonacci
139.18
140.61
141.49
142.93
144.36
145.24
146.68
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Insmed (INSM) Moving Averages

Sep 07, 2025, 03:53 PM
Period
Simple
Exponential
MA5
142.51Buy
142.10Buy
MA10
137.44Buy
138.21Buy
MA20
130.69Buy
131.32Buy
MA50
113.95Buy
116.79Buy
MA100
95.15Buy
103.22Buy
MA200
84.82Buy
90.71Buy
Insmed’s (INSM) 10-Day exponential moving average is 138.21, while Insmed’s (INSM) share price is $145.1, making it a Buy.
Insmed’s (INSM) 100-Day exponential moving average is 103.22, while Insmed’s (INSM) share price is $145.1, making it a Buy.
Insmed’s (INSM) stock price is $145.1 and Insmed’s (INSM) 50-day simple moving average is 113.95, creating a Buy signal.
Insmed’s (INSM) stock price is $145.1 and Insmed’s (INSM) 100-day simple moving average is 95.15, creating a Buy signal.
Insmed’s (INSM) stock price is $145.1 and Insmed’s (INSM) 200-day simple moving average is 84.82, creating a Buy signal.

Insmed (INSM) Technical Indicators

Sep 07, 2025, 03:53 PM
Name
Value
Implied Action
RSI (14)
79.86
Sell
STOCH (9,6)
83.37
Sell
STOCHRSI (14)
86.01
Sell
MACD (12,26)
8.93
Sell
ADX (14)
57.81
Sell
Williams %R
-8.34
Sell
CCI (14)
124.06
Sell
ATR (14)
4.06
-
Ultimate Oscillator
68.30
Neutral
ROC
13.54
Buy
Insmed’s (INSM) Relative Strength Index (RSI) is 79.86, creating a Sell signal.
Insmed’s (INSM) Trend Strength Indicator (ADX) is 57.81, creating a Sell signal.
Insmed’s (INSM) Commodity Channel Index (CCI) is 124.06, creating a Sell signal.
Insmed’s (INSM) Price Rate of Change (ROC) is 13.54, creating a Buy signal.

FAQ

Is INSM a Buy, Hold, or Sell?
Based on INSM’s technical indicators, INSM is a Buy.
    What is INSM’s RSI (14)?
    INSM’s RSI (14) is 79.86, which suggests INSM is a Sell.
      What is INSM’s MACD?
      INSM’s MACD is 8.93, which suggests INSM is a Sell.
        What is INSM’s 5-day moving average?
        INSM’s 5-day moving average is 142.51, which suggests INSM is a Buy.
          What is INSM’s 20-day moving average?
          INSM 20-day moving average is 130.69, which suggests INSM is a Buy.
            What is INSM’s 50-day moving average?
            INSM’s 50-day moving average is 113.95, which suggests INSM is a Buy.
              What is INSM’s 200-day moving average?
              INSM’s 200-day moving average is 84.82, which suggests INSM is a Buy.
                What is INSM’s Williams % R (14)?
                INSM’s Williams % R (14) is -8.34, which suggests INSM is a Sell.
                  What is INSM’s CCI (14)?
                  INSM’s CCI (14) is 124.06, which suggests INSM is a Sell.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis